DoD Rare Cancers, Idea Development Award

The Department of Defense's (DOD) Fiscal Year 2024 Rare Cancers Research Program (RCRP) is offering the Idea Development Award to promote new early-stage ideas with high potential to improve outcomes for individuals with rare cancers. The award supports research based on strong scientific rationale and preliminary data, which may come from outside the rare cancers field. Applicants must address at least one of the three FY24 RCRP focus areas: Biology, Research, or Therapy. The program seeks innovative research, including that involving nuclear medicine techniques, to support early diagnosis, more effective treatment, and improved health outcomes. Eligible applicants include extramural and intramural organizations, and collaborations between academia, industry, the military, and government agencies are highly encouraged. Clinical trials are not allowed.

The anticipated direct costs budgeted for the entire period of performance should not exceed $350,000. The DOD expects to fund approximately 11 awards from the $6.16 million available. The pre-application deadline is June 17, 2024, and the full application deadline is September 23, 2024. Awards will be funded with FY24 funds and must be executed by September 30, 2025.